Nurix (NRIX) Opportunistically Strengthened Balance Sheet Ahead of Catalysts, PT to $37 - Stifel
Tweet Send to a Friend
Stifel analyst Stephen Willey lowered the price target on Nurix (NASDAQ: NRIX) to $37.00 (from $44.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
